TAS-102 in combination with bevacizumab for second-line treatment of metastatic colorectal cancer with a hypertensive elderly patient: a case report
TAS-102 in combination with bevacizumab for the treatment of elderly patients with metastatic CRC who are ineligible for intensive therapy is a promising treatment option.
Authors
- Xun Qiu (ORCID: https://orcid.org/0000-0001-5930-1877)
- Qing He (ORCID: https://orcid.org/0000-0003-2899-0950)
- Lili Liu (ORCID: https://orcid.org/0000-0002-4347-2038)
- Lingling Xu (ORCID: https://orcid.org/0000-0003-1341-4141)
- Hongmei He (ORCID: https://orcid.org/0000-0002-4157-7434)
- Jinghua Sun
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Dalian Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-03-28
- DOI
- https://doi.org/10.3389/fonc.2025.1558470
- Citations
- 1
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.05